Michal Beffinger

Institute of Laboratory Animal Science

University of Zurich

BIOGRAPHY

Ph.D. in cancer immunology, over eight years of hands-on experience in research and teaching, engineer trained in technical design, co-founder of a start-up web

platform. Focused on technology commercialization and bringing to the market novel therapies for central nervous system diseases.

PUBLICATIONS

Rational Combination of Immunotherapies with Clinical Efficacy in Mice with Advanced Cancer.

Cancer immunology research Nov, 2015 | Pubmed ID: 26141620

Stromal Expression of Activated Leukocyte Cell Adhesion Molecule Promotes Lung Tumor Growth and Metastasis.

The American journal of pathology Nov, 2017 | Pubmed ID: 28822802

CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis.

JCI insight 05, 2018 | Pubmed ID: 29769439

INSTITUTIONS

University of Zurich

JOVE ARTICLES

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

Michal Beffinger¹,

Linda Schellhammer¹,

Stanislav Pantelyushin¹,

Johannes vom Berg¹

¹Institute of Laboratory Animal Science, University of Zurich

Neuroscience

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

Michal Beffinger

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Institute of Laboratory Animal Science

University of Zurich

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

Institute of Laboratory Animal Science